DONALD JOSEPH

Profile

First Name

: DONALD

Middle Name

:

Last Name

: JOSEPH

Related Companies

Titles

Company Name

Related People

EXECUTIVE OFFICER

HIGHWAY TO HEALTH, INC.

SCOTT BEACHAM, CHRISTOPHER BUTLER, DENNIS CASEY, ANDREW CONN, JAMES DEYLING, JOSEPH HENRY, ALAN KRIGSTEIN, ALLEN MALTZ, ANGELO MASCIANTONIO, JAMES MESSINA, YORI MILO, MICHAEL MIZEUR, DAVID PANKAU, STEVE SCHLEGAL, STEVEN SCHLEGEL, LAWRENCE SCHREIBER, LAWRENCE SCHRIEBER

DIRECTOR, EXECUTIVE OFFICER

SORBENT THERAPEUTICS INC

DETLEF ALBRECHT, LINDA ARA, DAVID COLLIER, LINDA DE YOUNG, HOWARD C. DITTRICH, MARCUS GOEBEL, MARKUS GOEBEL, JAMES HEALY, JAMES I. HEALY, JASON LEVIN, SCOTT MINICK, THOMAS P. O-NEIL, WILLIAM RAJSKI, RANDALL WOODS

DIRECTOR

ACHIEVE LIFE SCIENCES, INC.

STEPHEN ANDERSON, JOHN BENCICH, MICHELLE BURRIS, ANTHONY CLARKE, NEIL JAMES CLENDENINN, SCOTT CORMACK, VAUGHN HIMES, CINDY JACOBS, BRIDGET MARTELL, MICHAEL A. MARTINO, MARTIN MATTINGLY, JAY MOYES, RICHARD STEWART, DWIGHT WINSTEAD, JAIME XINOS

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D/A

BIOTECHNOLOGY

IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]

DECLINE TO DISCLOSE

2022-11-18

D

BIOTECHNOLOGY

IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]

DECLINE TO DISCLOSE

2022-11-18

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2014-04-30

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2012-07-27

D

INSURANCE

DECLINE TO DISCLOSE

Equity

2012-06-12

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Debt

2012-05-31

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2011-06-14

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2010-06-30

D

INSURANCE

DECLINE TO DISCLOSE

Equity

2010-05-26

D

INSURANCE

DECLINE TO DISCLOSE

Equity, Debt

2009-07-02